Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01451814 · ClinicalTrials.gov registry record · Phase 2

Development of Positive Psychotherapy for Smoking Cessation

A Phase 2 study, sponsored by Brown University.

Completed
Registry status
Phase 2
Development phase
66
Enrollment target

NCT01451814 is a Phase 2 study that has completed, run by Brown University. The registered enrollment target is 66 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01451814, a Phase 2 study, has completed, sponsored by Brown University.

COMPLETED
Registry status
Phase 2
Development phase
66 participants
Enrollment target

Study Summary

The primary objective of this study is to test a manualized adaptation of positive psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a preliminary randomized clinical trial (N = 80) to examine the feasibility, acceptability, and efficacy of PPT-S over 26 weeks of follow up in comparison to a standard smoking cessation treatment. Both treatments will be delivered in individual 6 sessions over 6 weeks, and will include provision of transdermal nicotine patch. The effect size estimates from this Stage 1b research will provide the foundation for a future application to conduct a large-scale, Stage II, randomized clinical trial.

Interventions

  • BEHAVIORAL Relaxation training
  • DRUG Nicotine polacrilex
  • BEHAVIORAL Positive Psychotherapy for smoking cessation
  • BEHAVIORAL Behavioral smoking cessation treatment

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2011-10
Est. Completion 2014-02
Phase Phase 2

Sponsor

Brown University

231 total trials

What the Registry Record Tells You About NCT01451814

The ClinicalTrials.gov registry entry for NCT01451814 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Relaxation training is the first listed.

NCT01451814 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01451814 about?

NCT01451814 is a clinical study titled "Development of Positive Psychotherapy for Smoking Cessation". The primary objective of this study is to test a manualized adaptation of positive psychotherapy (PPT) for smoking cessation (PPT-S). The investigators will conduct a preliminary randomized clinical trial (N = 80) to examine the feasibility, acceptability, and efficacy of PPT-S over 26 weeks of foll...

What is the current status of trial NCT01451814?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2011-10. Estimated completion is 2014-02.

What interventions are being tested in trial NCT01451814?

The interventions under investigation include: Relaxation training (BEHAVIORAL), Nicotine polacrilex (DRUG), Positive Psychotherapy for smoking cessation (BEHAVIORAL), Behavioral smoking cessation treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01451814?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.